<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Recash test site | Carr Rask | Activity</title>
	<link>https://recash.wpsoul.net/members/adultpin7/activity/</link>
	<atom:link href="https://recash.wpsoul.net/members/adultpin7/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Carr Rask.</description>
	<lastBuildDate>Wed, 20 May 2026 10:39:11 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">8ec2bc3cc73c0226793c686f18f18c9c</guid>
				<title>Carr Rask posted an update: Oncolytic adenovirus (OA) has attracted increasing attention [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/56182/</link>
				<pubDate>Wed, 11 Dec 2024 23:16:54 +0000</pubDate>

									<content:encoded><![CDATA[<p>Oncolytic adenovirus (OA) has attracted increasing attention due to their specific proliferation in tumour cells and resulting in lysis of tumour cells. To further improve the antitumour effect of OA, in this study, we combined CD55-TRAIL-IETD-MnSOD (CD55-TMn), a CEA-controlled OA constructed previously, and chemotherapy to investigate their&hellip;<span class="activity-read-more" id="activity-read-more-56182"><a href="https://recash.wpsoul.net/activity/p/56182/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">4cad60ec99bd53dfb00b87d837185056</guid>
				<title>Carr Rask became a registered member</title>
				<link>https://recash.wpsoul.net/activity/p/56060/</link>
				<pubDate>Wed, 11 Dec 2024 23:04:58 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>